REPL Replimune Group, Inc.
Nasdaq · SEC CIK 1737953 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.93M 17 sales by 7 insiders
- Filings on record
- 162 since 2021-07-07, latest 2026-08-24 19:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Patel Sushil | CEO, Dir | — | $811.2K |
| Hill Emily Luisa | CFO | — | $320.3K |
| Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| Schwendenman Andrew | CAO | — | $139.1K |
| Astley-Sparke Philip | Dir | — | $89.7K |
| Dhingra Kapil | Dir | — | $33.0K |
Transactions 132
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 19:48 | 2026-08-20 | REPL | Astley-Sparke Philip | Dir | G - Gift | $0.00 | -50.0K | 1.36M | -4% | $0 | |
| 2026-08-19 18:42 | 2026-08-17 | REPL | Hill Emily Luisa | CFO | S - Sale | $14.28 | -9,256 | 215.9K | -4% | -$132.2K | |
| 2026-08-12 17:07 | 2026-08-10 | REPL | Patel Sushil | CEO, Dir | S - Sale | $12.97 | -39.3K | 708.2K | -5% | -$510.3K | |
| 2026-08-12 17:06 | 2026-08-10 | REPL | Hill Emily Luisa | CFO | S - Sale | $12.97 | -11.4K | 225.1K | -5% | -$148.5K | |
| 2026-08-12 17:05 | 2026-08-10 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $12.97 | -11.4K | 224.2K | -5% | -$148.5K | |
| 2026-08-12 17:04 | 2026-08-10 | REPL | Schwendenman Andrew | CAO | S - Sale | $12.97 | -7,632 | 99.4K | -7% | -$99.0K | |
| T | 2026-06-03 20:30 | 2026-06-01 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $9.24 | -12.0K | 181.0K | -6% | -$110.9K |
| 2026-05-20 16:18 | 2026-05-18 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $5.08 | -14.0K | 235.7K | -6% | -$71.2K | |
| 2026-05-20 16:17 | 2026-05-18 | REPL | Schwendenman Andrew | CAO | S - Sale | $5.08 | -7,894 | 107.1K | -7% | -$40.1K | |
| 2026-05-20 16:16 | 2026-05-18 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $5.08 | -8,626 | 193.0K | -4% | -$43.8K | |
| 2026-05-20 16:16 | 2026-05-18 | REPL | Astley-Sparke Philip | Dir | S - Sale | $5.08 | -17.7K | 1.41M | -1% | -$89.7K | |
| 2026-05-20 16:15 | 2026-05-18 | REPL | Patel Sushil | CEO, Dir | S - Sale | $5.08 | -37.3K | 747.5K | -5% | -$189.6K | |
| 2026-05-20 16:15 | 2026-05-18 | REPL | Hill Emily Luisa | CFO | S - Sale | $5.08 | -7,812 | 236.6K | -3% | -$39.7K | |
| D | 2026-04-07 21:11 | 2026-04-01 | REPL | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +50.0K | 201.6K | +33% | $0 |
| D | 2026-04-07 21:10 | 2026-04-01 | REPL | Astley-Sparke Philip | Dir | A - Grant | $0.00 | +50.0K | 1.43M | +4% | $0 |
| D | 2026-04-07 21:10 | 2026-04-01 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +50.0K | 249.7K | +25% | $0 |
| D | 2026-04-07 21:09 | 2026-04-01 | REPL | Schwendenman Andrew | CAO | A - Grant | $0.00 | -36.7K | 115.0K | -24% | $0 |
| D | 2026-04-07 21:09 | 2026-04-01 | REPL | Patel Sushil | CEO, Dir | A - Grant | $0.00 | +251.2K | 784.8K | +47% | $0 |
| D | 2026-04-07 21:08 | 2026-04-01 | REPL | Hill Emily Luisa | CFO | A - Grant | $0.00 | +50.0K | 244.4K | +26% | $0 |
| T | 2026-04-06 16:30 | 2026-04-02 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $8.01 | -6,500 | 151.6K | -4% | -$52.1K |
| 2026-02-20 | 2026-02-18 | REPL | Astley-Sparke Philip | Dir | G - Gift | $0.00 | -25.0K | 1.38M | -2% | $0 | |
| 2025-12-19 | 2025-12-19 | REPL | Hill Emily Luisa | CFO | A - Grant | $0.00 | +60.0K | 194.4K | +45% | $0 | |
| 2025-12-19 | 2025-12-19 | REPL | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +35.0K | 158.1K | +28% | $0 | |
| 2025-12-19 | 2025-12-19 | REPL | Schwendenman Andrew | CAO | A - Grant | $0.00 | +10.0K | 78.3K | +15% | $0 | |
| 2025-12-19 | 2025-12-19 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +60.0K | 199.7K | +43% | $0 | |
| 2025-12-19 | 2025-12-19 | REPL | Patel Sushil | CEO, Dir | A - Grant | $0.00 | +200.0K | 533.6K | +60% | $0 | |
| D | 2025-12-11 | 2025-12-09 | REPL | Dhingra Kapil | Dir | S - Sale+OE | $10.40 | -3,169 | 0 | -100% | -$33.0K |
| D | 2025-12-11 | 2025-12-09 | REPL | Dhingra Kapil | Dir | M - OptEx | $1.75 | +3,169 | 3,169 | New | +$5,546 |
| 2025-12-04 | 2025-12-02 | REPL | Patel Sushil | CEO, Dir | S - Sale | $11.13 | -10.0K | 333.6K | -3% | -$111.3K | |
| 2025-11-19 | 2025-11-17 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $9.10 | -5,208 | 123.1K | -4% | -$47.4K | |
| 2025-11-19 | 2025-11-17 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $9.10 | -7,248 | 139.7K | -5% | -$66.0K | |
| 2025-08-19 | 2025-08-15 | REPL | Hill Emily Luisa | CFO | S - Sale | $5.37 | -9,154 | 134.4K | -6% | -$49.2K | |
| 2025-05-22 | 2025-05-20 | REPL | Astley-Sparke Philip | Dir | S - Sale | $8.06 | -32.3K | 1.41M | -2% | -$260.2K | |
| 2025-05-22 | 2025-05-20 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $8.05 | -3,749 | 128.3K | -3% | -$30.2K | |
| 2025-05-22 | 2025-05-20 | REPL | Patel Sushil | CEO, Dir | S - Sale | $8.06 | -25.1K | 343.6K | -7% | -$202.3K | |
| 2025-05-22 | 2025-05-20 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $8.06 | -7,952 | 146.9K | -5% | -$64.1K | |
| 2025-05-22 | 2025-05-20 | REPL | Hill Emily Luisa | CFO | S - Sale | $8.05 | -2,535 | 143.5K | -2% | -$20.4K | |
| 2025-05-22 | 2025-05-20 | REPL | Schwendenman Andrew | CAO | S - Sale | $8.05 | -3,287 | 68.3K | -5% | -$26.5K | |
| D | 2025-04-03 | 2025-04-01 | REPL | Schwendenman Andrew | CAO | A - Grant | $0.00 | -33.3K | 71.6K | -32% | $0 |
| D | 2025-04-03 | 2025-04-01 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +45.0K | 154.9K | +41% | $0 |
| D | 2025-04-03 | 2025-04-01 | REPL | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +45.0K | 132.0K | +52% | $0 |
| D | 2025-04-03 | 2025-04-01 | REPL | Patel Sushil | CEO, Dir | A - Grant | $0.00 | +166.7K | 368.7K | +83% | $0 |
| D | 2025-04-03 | 2025-04-01 | REPL | Hill Emily Luisa | CFO | A - Grant | $0.00 | +45.0K | 146.1K | +45% | $0 |
| 2024-12-18 | 2024-12-16 | REPL | Patel Sushil | CEO, Dir | S - Sale | $12.42 | -10.0K | 202.0K | -5% | -$124.2K | |
| 2024-11-20 | 2024-11-18 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $10.78 | -7,246 | 109.9K | -6% | -$78.1K | |
| 2024-11-20 | 2024-11-18 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $10.78 | -5,207 | 87.0K | -6% | -$56.1K | |
| 2024-08-30 | 2024-08-30 | REPL | Astley-Sparke Philip | Executive COB, Dir | G - Gift | $0.00 | -50.0K | 1.44M | -3% | $0 | |
| 2024-08-19 | 2024-08-16 | REPL | Hill Emily Luisa | CFO | S - Sale | $10.18 | -8,938 | 101.1K | -8% | -$91.0K | |
| 2024-06-10 | 2024-06-07 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $7.50 | -15.9K | 117.1K | -12% | -$119.1K | |
| 2024-05-20 | 2024-05-16 | REPL | Patel Sushil | CEO, Dir | S - Sale | $6.47 | -20.2K | 212.0K | -9% | -$130.7K | |
| 2024-05-20 | 2024-05-16 | REPL | Coffin Robert | Dir | S - Sale | $6.47 | -11.5K | 1.82M | -0.6% | -$74.2K | |
| 2024-05-20 | 2024-05-16 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $6.47 | -6,367 | 133.0K | -5% | -$41.2K | |
| 2024-05-20 | 2024-05-16 | REPL | Astley-Sparke Philip | Executive COB, Dir | S - Sale | $6.47 | -37.9K | 1.49M | -2% | -$245.4K | |
| 2024-05-20 | 2024-05-16 | REPL | Schwendenman Andrew | CAO | S - Sale | $6.47 | -2,298 | 38.2K | -6% | -$14.9K | |
| 2024-05-20 | 2024-05-16 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $6.47 | -2,218 | 92.3K | -2% | -$14.4K | |
| 2024-05-20 | 2024-05-16 | REPL | Love Colin | COO | S - Sale | $6.47 | -17.6K | 777.3K | -2% | -$114.0K | |
| D | 2024-04-03 | 2024-04-01 | REPL | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +22.2K | 94.5K | +31% | $0 |
| D | 2024-04-03 | 2024-04-01 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +26.7K | 139.4K | +24% | $0 |
| D | 2024-04-03 | 2024-04-01 | REPL | Schwendenman Andrew | CAO | A - Grant | $0.00 | +17.8K | 40.5K | +78% | $0 |
| D | 2024-04-03 | 2024-04-01 | REPL | Patel Sushil | CEO, Dir | A - Grant | $0.00 | +83.3K | 232.2K | +56% | $0 |
| D | 2024-04-03 | 2024-04-01 | REPL | Hill Emily Luisa | CFO | A - Grant | $0.00 | +26.7K | 110.0K | +32% | $0 |
| 2023-11-17 | 2023-11-16 | REPL | Sarchi Christopher | Chief Commercial Off | S - Sale | $10.92 | -5,255 | 72.2K | -7% | -$57.4K | |
| 2023-11-17 | 2023-11-16 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $10.92 | -7,313 | 112.7K | -6% | -$79.9K | |
| D | 2023-09-20 | 2023-09-18 | REPL | Hill Emily Luisa | CFO | A - Grant | $0.00 | +83.3K | 83.3K | New | $0 |
| DM | 2023-09-13 | 2023-09-11+ | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $3.30 | +5,658 | 263.7K | +2% | +$18.7K |
| DM | 2023-09-13 | 2023-09-11+ | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $20.01 | -5,658 | 263.4K | -2% | -$113.2K |
| DM | 2023-08-24 | 2023-08-22 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $6.58 | +18.6K | 282.0K | +7% | +$122.4K |
| D | 2023-08-24 | 2023-08-22 | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $20.01 | -18.6K | 263.4K | -7% | -$372.2K |
| D | 2023-08-15 | 2023-08-11 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $3.30 | +1,400 | 264.8K | +0.5% | +$4,620 |
| D | 2023-08-15 | 2023-08-11 | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $20.00 | -1,400 | 263.4K | -0.5% | -$28.0K |
| DM | 2023-07-11 | 2023-07-10 | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $21.58 | -20.0K | 263.4K | -7% | -$431.5K |
| DM | 2023-07-11 | 2023-07-10 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $6.35 | +20.0K | 278.4K | +8% | +$127.0K |
| M | 2023-06-15 | 2023-06-13 | REPL | Patel Sushil | Chief Strategy Off | S - Sale | $24.04 | -5,698 | 148.9K | -4% | -$137.0K |
| M | 2023-06-15 | 2023-06-13 | REPL | Lewis Tanya | Chief Dev. Op. Off | S - Sale | $24.06 | -12.9K | 135.3K | -9% | -$309.4K |
| 2023-05-18 | 2023-05-16 | REPL | Patel Sushil | Chief Strategy Off | S - Sale | $18.05 | -15.6K | 154.6K | -9% | -$281.1K | |
| 2023-05-18 | 2023-05-16 | REPL | Franchi Jean M. | CFO | S - Sale | $18.05 | -11.4K | 128.7K | -8% | -$204.9K | |
| 2023-05-18 | 2023-05-16 | REPL | Astley-Sparke Philip | CEO, Dir | S - Sale | $18.05 | -17.9K | 1.53M | -1% | -$323.1K | |
| 2023-05-18 | 2023-05-16 | REPL | Xynos Konstantinos | Chief Medical Off | S - Sale | $18.05 | -771 | 120.0K | -0.6% | -$13.9K | |
| 2023-05-18 | 2023-05-16 | REPL | Coffin Robert | Pres, Chief R, D Off, Dir | S - Sale | $18.05 | -7,861 | 1.83M | -0.4% | -$141.9K | |
| 2023-05-18 | 2023-05-16 | REPL | Esposito Pamela | Chief Business Off | S - Sale | $18.05 | -5,966 | 263.4K | -2% | -$107.7K | |
| 2023-05-18 | 2023-05-16 | REPL | Love Colin | COO | S - Sale | $18.05 | -10.8K | 795.0K | -1% | -$194.5K | |
| 2023-05-18 | 2023-05-16 | REPL | Lewis Tanya | Chief Dev. Op. Off | S - Sale | $18.05 | -12.2K | 148.2K | -8% | -$220.3K | |
| D | 2023-04-04 | 2023-04-01 | REPL | Esposito Pamela | Chief Business Off | A - Grant | $0.00 | +40.0K | 269.4K | +17% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Love Colin | COO | A - Grant | $0.00 | +40.0K | 805.7K | +5% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Coffin Robert | Pres, Chief R, D Off, Dir | A - Grant | $0.00 | +45.0K | 1.84M | +3% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Astley-Sparke Philip | CEO, Dir | A - Grant | $0.00 | +142.1K | 1.54M | +10% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Patel Sushil | Chief Strategy Off | A - Grant | $0.00 | +40.0K | 170.1K | +31% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Lewis Tanya | Chief Dev. Op. Off | A - Grant | $0.00 | +40.0K | 160.4K | +33% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +50.0K | 120.8K | +71% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Franchi Jean M. | CFO | A - Grant | $0.00 | +45.0K | 140.1K | +47% | $0 |
| D | 2022-12-13 | 2022-12-09 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $1.01 | +15.0K | 244.4K | +7% | +$15.2K |
| D | 2022-12-13 | 2022-12-09 | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $25.03 | -15.0K | 229.4K | -6% | -$375.4K |
| D | 2022-12-05 | 2022-12-01 | REPL | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +17.5K | 70.8K | +33% | $0 |
| 2022-05-18 | 2022-05-16 | REPL | Patel Sushil | Chief Commercial Off | S - Sale | $14.59 | -10.7K | 130.1K | -8% | -$155.9K | |
| 2022-05-18 | 2022-05-16 | REPL | Love Colin | COO | S - Sale | $14.59 | -6,324 | 765.7K | -0.8% | -$92.3K | |
| 2022-05-18 | 2022-05-16 | REPL | Franchi Jean M. | CFO | S - Sale | $14.59 | -3,436 | 95.1K | -3% | -$50.1K | |
| 2022-05-18 | 2022-05-16 | REPL | Lewis Tanya | Chief Dev. Op Off | S - Sale | $14.59 | -5,473 | 120.4K | -4% | -$79.9K | |
| 2022-05-18 | 2022-05-16 | REPL | Astley-Sparke Philip | CEO, Dir | S - Sale | $14.59 | -9,632 | 1.40M | -0.7% | -$140.5K | |
| 2022-05-18 | 2022-05-16 | REPL | Esposito Pamela | Chief Business Off | S - Sale | $14.59 | -3,507 | 229.4K | -2% | -$51.2K | |
| 2022-05-18 | 2022-05-16 | REPL | Coffin Robert | Pres, Chief R, D Off, Dir | S - Sale | $14.59 | -5,737 | 1.80M | -0.3% | -$83.7K |
Purchase Sale Sale after option exercise All abbreviations